Loading...
•
Feb 28, 2021
AngioDynamics Q3 2021 Earnings Report
Net sales increased and adjusted earnings per share was reported.
Key Takeaways
AngioDynamics reported a 2.0% increase in net sales compared to the prior-year quarter. The company's revenue grew despite COVID-19 headwinds. The company is raising its fiscal year 2021 guidance.
Net sales of $71.2 million increased 2.0% compared to the prior-year quarter
Gross margin of 54.1%, a decline of 370 basis points year over year
GAAP loss per share of $0.09 and adjusted earnings per share of $0.02
Cash and cash equivalents on February 28, 2021 were $54.5 million
Revenue by Geographic Location
Forward Guidance
The Company is increasing its guidance for fiscal year 2021. Management now projects net sales between $285 and $288 million and fiscal year 2021 adjusted earnings per share between $0.04 and $0.06, compared to previous projections of net sales between $278 and $284 million and adjusted earnings per share between $0.00 and $0.05.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...